sesamin has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, F; Guo, L; Liu, X; Xu, P | 1 |
| Aggarwal, BB; Guha, S; Harikumar, KB; Joy, B; Krishnan, S; Pandey, MK; Sung, B; Tharakan, ST | 1 |
| Erben, U; Freise, C; Kim, KY; Ruehl, M; Seehofer, D; Somasundaram, R; Trowitzsch-Kienast, W; Zeitz, M | 1 |
3 other study(ies) available for sesamin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-κB signaling pathways in prostate cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cytokines; Dioxoles; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lignans; Lipopolysaccharides; Male; Neoplasm Invasiveness; Neoplasm Proteins; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostatic Neoplasms; Pyridines; Signal Transduction | 2015 |
Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
Topics: Angiogenic Proteins; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxoles; Growth Inhibitors; Humans; Lignans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Sesame Oil; Signal Transduction | 2010 |
(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Dioxoles; Humans; Interleukin-6; Lignans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; NF-kappa B; Vascular Endothelial Growth Factor A | 2012 |